Skip to main content

Table 1 Demographics of the cohort of COPD patients (n = 39,879)

From: Statin use and lung cancer risk in chronic obstructive pulmonary disease patients: a population-based cohort study

Patient Characteristic

Value

Age

70.6 (SD: 11.2)

Age Distribution

 50 < 60

8356 (21.0%)

 60 < 70

10,212 (25.7%)

 70 < 80

12,436 (31.2%)

  ≥ 80

8785 (22.1%)

Female

21,273 (53.5%)

Income Quintile

 1

9701 (25.6%)

 2

7864 (20.8%)

 3

6854 (18.1%)

 4

6381 (16.8%)

 5

5696 (15.0%)

Health Authority

 Interior

8569 (21.6%)

 Fraser

11,354 (28.6%)

 Vancouver Coastal

7740 (19.5%)

 Vancouver Island

7522 (18.6%)

 Northern

2465 (6.2%)

Hospitalizations

6651 (16.7%

 Any Reason

6651 (16.7%

 COPD-related

1084 (2.7%)

 CVD-related

512 (1.3%)

Charlson Comorbidity Categorya

 0

31,354 (79.0%)

 1

6303 (15.9%)

 2

1176 (3.0%)

  ≥ 3

843 (2.1%)

Combination Therapy (ICS/LABA)

6585 (16.5%)

Physician Encounters (any reason)b

11 (3–22)

Number of Prescriptions Received (any reason)b

21 (7–44)

  1. Values represent mean (standard deviation) or number (percentage) unless otherwise indicated
  2. Where percentages do not add to 100% the reason is due to rounding
  3. aCategory 0 is a Charlson Score of 0, Category 1 is (0,2], Category 2 is (2, 3], Category 3 is > 3. This calculation excludes COPD, CVD, and cancer. bMedian and interquartile ranges